Screener
Allarity Therapeutics, Inc. ALLR Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$0.21Beat by $0.04
EPS estimate-$0.25
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.25
Versus estimates
Diluted EPS
FAQ
- When did Allarity Therapeutics, Inc. report Q2 2026 earnings?
- Allarity Therapeutics, Inc. (ALLR) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Allarity Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Allarity Therapeutics, Inc. reported eps of $-0.21 for Q2 2026.
- Did Allarity Therapeutics, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.25 by $0.04.
- How did Allarity Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 40.0% from $-0.15.
- Where can I find Allarity Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001213900-26-090183) and the 10-Q periodic report (0001437749-26-027830) directly on SEC EDGAR. The filing index links above go to sec.gov.
